Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2013-06-01
|
Series: | Научно-практическая ревматология |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1663 |
_version_ | 1826556102491242496 |
---|---|
author | Yuri Vladimirovich Muravyev G I Gridina D E Karateev |
author_facet | Yuri Vladimirovich Muravyev G I Gridina D E Karateev |
author_sort | Yuri Vladimirovich Muravyev |
collection | DOAJ |
first_indexed | 2024-04-09T22:25:39Z |
format | Article |
id | doaj.art-dd025cb4f54a43f08d1cedb731203067 |
institution | Directory Open Access Journal |
issn | 1995-4484 1995-4492 |
language | Russian |
last_indexed | 2025-03-14T08:07:22Z |
publishDate | 2013-06-01 |
publisher | IMA PRESS LLC |
record_format | Article |
series | Научно-практическая ревматология |
spelling | doaj.art-dd025cb4f54a43f08d1cedb7312030672025-03-02T13:23:38ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922013-06-0151335435610.14412/1995-4484-2013-15141600Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumabYuri Vladimirovich MuravyevG I GridinaD E Karateevhttps://rsp.mediar-press.net/rsp/article/view/1663 |
spellingShingle | Yuri Vladimirovich Muravyev G I Gridina D E Karateev Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab Научно-практическая ревматология |
title | Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
title_full | Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
title_fullStr | Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
title_full_unstemmed | Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
title_short | Thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
title_sort | thromboembolism is an unexpected poor response resulting from the use of the tumor necrosis factor inhibitor adalimumab |
url | https://rsp.mediar-press.net/rsp/article/view/1663 |
work_keys_str_mv | AT yurivladimirovichmuravyev thromboembolismisanunexpectedpoorresponseresultingfromtheuseofthetumornecrosisfactorinhibitoradalimumab AT gigridina thromboembolismisanunexpectedpoorresponseresultingfromtheuseofthetumornecrosisfactorinhibitoradalimumab AT dekarateev thromboembolismisanunexpectedpoorresponseresultingfromtheuseofthetumornecrosisfactorinhibitoradalimumab |